文献速递炎症性肠病消化内镜

Grem1拮抗BMP通路调控肠道再生中的上皮细胞命运

Bone Morphogenetic Protein Pathway Antagonism by Grem1 Regulates Epithelial Cell Fate in Intestinal Regeneration.
PubMed 文献 · Gastroenterology · 2021-04-02

该研究通过新型小鼠模型和转基因模型,发现生理状态下BMP信号抑制增殖、促进分化并阻止去分化;溃疡后成纤维细胞上调Grem1减弱BMP信号,是肠道再生中适应性重编程所必需的。BMP通路拮抗功能上非最大,提示治疗性调控可能。

要点

  • BMP信号阻止上皮去分化,维持分化状态。
  • 溃疡后成纤维细胞来源Grem1减弱BMP信号,支持再生重编程。
  • 拮抗BMP通路的功能非最大,有治疗调控空间。

核心结论

  • BMP信号阻止上皮去分化,基质Grem1上调介导的BMP通路减弱是肠道再生适应性重编程所必需的。
  • 该区室间拮抗在功能上非最大,提示炎症性肠病治疗性通路调控的可能性。

研究设计与样本

  • 研究生成新型小鼠模型评估自分泌Bmp4配体对单个分泌细胞命运的影响,并在小鼠和人再生肠道中时空映射BMP信号。
  • 使用转基因模型探索通路调控对干细胞命运和肠道再生的功能影响。

主要发现

  • 稳态下配体暴露减少增殖、加速终末分化、消除分泌细胞存活并阻止去分化。
  • 溃疡后BMP信号生理性减弱,源于拓扑不同成纤维细胞群体上调分泌拮抗剂Grem1。
  • Grem1缺失后组织驻留细胞的伴随表达支持功能补偿。
  • 拮抗剂介导的BMP减弱是必需但功能上非最大的,因为上皮过表达Bmp4或Grem1分别损害或增强再生。
  • 机制上,Bmp4消除再生干细胞重编程,尽管YAP/TAZ对重塑伤口中细胞命运有汇聚影响。

临床怎么用

  • 在炎症性肠病中,靶向BMP通路拮抗可能促进肠道再生。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: In homeostasis, intestinal cell fate is controlled by balanced gradients of morphogen signaling. The bone morphogenetic protein (BMP) pathway has a physiological, prodifferentiation role, predominantly inferred through previous experimental pathway inactivation. Intestinal regeneration is underpinned by dedifferentiation and cell plasticity, but the signaling pathways that regulate this adaptive reprogramming are not well understood. We assessed the BMP signaling landscape and investigated the impact and therapeutic potential of pathway manipulation in homeostasis and regeneration. METHODS: A novel mouse model was generated to assess the effect of the autocrine Bmp4 ligand on individual secretory cell fate. We spatiotemporally mapped BMP signaling in mouse and human regenerating intestine. Transgenic models were used to explore the functional impact of pathway manipulation on stem cell fate and intestinal regeneration. RESULTS: In homeostasis, ligand exposure reduced proliferation, expedited terminal differentiation, abrogated secretory cell survival, and prevented dedifferentiation. After ulceration, physiological attenuation of BMP signaling arose through upregulation of the secreted antagonist Grem1 from topographically distinct populations of fibroblasts. Concomitant expression supported functional compensation after Grem1 deletion from tissue-resident cells. BMP pathway manipulation showed that antagonist-mediated BMP attenuation was obligatory but functionally submaximal, because regeneration was impaired or enhanced by epithelial overexpression of Bmp4 or Grem1, respectively. Mechanistically, Bmp4 abrogated regenerative stem cell reprogramming despite a convergent impact of YAP/TAZ on cell fate in remodeled wounds. CONCLUSIONS: BMP signaling prevents epithelial dedifferentiation, and pathway attenuation through stromal Grem1 upregulation was required for adaptive reprogramming in intestinal regeneration. This intercompartmental antagonism was functionally submaximal, raising the possibility of therapeutic pathway manipulation in inflammatory bowel disease.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Koppens MAJ, Davis H, Valbuena GN, et al. Bone Morphogenetic Protein Pathway Antagonism by Grem1 Regulates Epithelial Cell Fate in Intestinal Regeneration. Gastroenterology. 2021. PMID: 33819486. doi:10.1053/j.gastro.2021.03.052

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。